Revenio Group Oyj (LON:0KFH)

Market Cap	424.10M -36.9%
Revenue (ttm)	95.87M +5.9%
Net Income	15.18M -5.9%
EPS	0.57 -5.8%
Shares Out	n/a
PE Ratio	27.94
Forward PE	21.86
Dividend	0.35 (1.67%)
Ex-Dividend Date	Apr 11, 2025

Volume	152,500
Average Volume	2,318
Open	21.00
Previous Close	22.70
Day's Range	20.82 - 21.00
52-Week Range	20.82 - 31.62
Beta	1.38
RSI	30.08
Earnings Date	Feb 11, 2026

About Revenio Group Oyj

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Probes that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare TONOVET Pro, a tonometer designed for use in surgical or emergency settings; and iCare TONOVET Plus tonometer, which is used for mea...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 2001
• Employees: 248
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0KFH

Financial Performance

In 2025, Revenio Group Oyj's revenue was 109.90 million, an increase of 5.86% compared to the previous year's 103.82 million. Earnings were 17.40 million, a decrease of -5.93%.

Financial numbers in EUR